Ziprasidone in Treatment of Resistant Obsessive-Compulsive Disorder in a Female Adolescent

AUTHORS

Ali Vahdani 1 , * , R Haghighat 2 , A Mani 2

1 Department of Psychiatry, Iranian Hospital, [email protected], UAE

2 College of Education and Psychology, Shiraz University, Fars, Iran

How to Cite: Vahdani A, Haghighat R, Mani A. Ziprasidone in Treatment of Resistant Obsessive-Compulsive Disorder in a Female Adolescent, Iran Red Crescent Med J. Online ahead of Print ; 11(4):461-463.

ARTICLE INFORMATION

Iranian Red Crescent Medical Journal: 11 (4); 461-463
Article Type: Case Report
Received: February 10, 2009
Accepted: July 5, 2009

Crossmark

CHEKING

READ FULL TEXT
Abstract

While serotonin reuptake inhibitors (SSRIs) and behavioral therapy are the first-line agents in treatment of obsessive-compulsive disorder (OCD), 40-60% of patients with the disorder do not respond to therapy. So other neurotransmitters may play a role in OCD. In this regard, there has been particular interest in the dopaminergic system, with various antipsychotic drugs having been used as adjunctive therapy for refractory OCD. This study describes the efficacy of ziprasidone as adjuncts for treatment-resistant OCD in a young female adolescent.

Keywords

Ziprasidone Obsessive-compulsive disorder Female Adolescent

© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Full Text

Full text is available in PDF

COMMENTS

LEAVE A COMMENT HERE: